نتایج جستجو برای: platelet concentrates

تعداد نتایج: 125901  

Journal: :Blood 1994
A P Bode S Holme W A Heaton M S Swanson

Preservation of platelet integrity and responsiveness was examined in platelet concentrates prepared in the presence of various formulations and combinations of platelet-activation inhibitors affecting intracellular levels of cyclic 3'-5' adenosine monophosphate (cAMP). Platelet concentrates were prepared and stored in an artificial medium for two weeks at 22 degrees C. Markers of metabolic act...

Journal: :Blood 1975
R H Herzig G P Herzig M I Bull J A Decter H P Lohrmann F G Stout R A Yankee R G Graw

Matching donor-recipient pairs for HL-A antigens provides a logical starting point for selecting donors for recipients with extensive prior transfusion histories. However, during the course of continued exposure to even HL-A-matched platelet concentrates, further sensitization occurs, as indicated by progressively poorer post-transfusion increments and transfusion reactions. There is evidence t...

Journal: :Vox sanguinis 2010
H Schrezenmeier E Seifried

There is an ongoing debate whether platelet concentrates (PCs) prepared from either whole-blood donations or by plateletpheresis are superior. Usage of these two product types varies greatly between countries and individual institutions. Some use mainly apheresis PCs; others prefer pooled PCs which are produced from whole-blood donations. This review summarizes the existing information on these...

Journal: :European cytokine network 2011
Torunn O Apelseth Tor Hervig Tore Wentzel-Larsen Kjell Petersen Håkon Reikvam Øystein Bruserud

BACKGROUND Platelet concentrates contain soluble mediators derived from both platelets and contaminating leukocytes. During platelet transfusion these mediators are transferred, and transfusion-induced modulation of the cytokine network may then occur, possibly contributing to transfusion reactions, immunomodulation, or affecting residual leukemic cells. In this prospective observational study,...

Journal: :iranian journal of blood and cancer 0
nasiri s

preparations of platelet concentrates (pcs) that are stored under blood bank conditions and used for transfusion purposes, appear to be enriched in platelet derived-microparticles (pmps) with high coagulant activity that may change platelet efficacy and safety issues. high shear stress could cause shedding of pmps from the platelet plasma membrane, platelet aggregation, and activation of the co...

Journal: :Blood transfusion = Trasfusione del sangue 2015
Azucena Castrillo Ignacio Álvarez Frank Tolksdorf

BACKGROUND Platelet concentrates may demonstrate visual, macroscopic clumps immediately after collection following aphaeresis or production from whole blood, independently of the preparation method or equipment used. The relationship between the occurrence of clumping and their effect on in vitro quality of platelets was investigated. MATERIAL AND METHODS Platelet concentrates, suspended in S...

Alireza Goodarzi, Fatemeh Yari, Hossin Timori Naghadeh, Mahshid Mohammadipour, Mohammad Reza Deyhim,

Background and Aims: Platelet factor 4 (PF4) or CXCL4 is a member of CXC chemokine family which is stored in alpha granules of platelets. The main function known for PF4 is angiostasis which may contribute to prevent tumor metastasis. This feature is mediated by CXCR3 on the endothelial cells. Our principal aim was to study the apoptosis induction in three cell lines treated with PF4 and obtain...

2017

In the recent years, the unique characteristics of mesenchymal stem cells (MSCs), consisting their angiogenesis and vascularization activity, as well as anti-inflammatory, anti-ulcer and immunosuppressive features plusdifferentiation capability into multilineage cell, have provided huge favorite among clinicians and researchers that theirs experiments has focused on treatment of different disea...

2013
Gines Escolar Victor Fernandez-Gallego Eduardo Arellano-Rodrigo Jaume Roquer Joan Carles Reverter Victoria Veronica Sanz Patricia Molina Irene Lopez-Vilchez Maribel Diaz-Ricart Ana Maria Galan

Apixaban is a new oral anticoagulant with a specific inhibitory action on FXa. No information is available on the reversal of the antihemostatic action of apixaban in experimental or clinical settings. We have evaluated the effectiveness of different factor concentrates at reversing modifications of hemostatic mechanisms induced by moderately elevated concentrations of apixaban (200 ng/ml) adde...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید